AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18222357
Drug: Bezafibrate therapy
RxNorm normalized name: bezafibrate
DrugBank: Bezafibrate (DB01393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate therapy
Trial: 1623913
Drug: Indomethacin (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (dosage not specified)
Trial: 25462201
Drug: Unilateral TAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral TAP block with 30 cc of 0.25% bupivacaine with 3 mcg/mL epinephrine
Trial: 30487248
Drug: GAD gene
RxNorm normalized name: Immature cell growth-inhibiting gene 1 protein
DrugBank: Cerliponase alfa (DB13173)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: GAD gene therapy delivered into the subthalamic nucleus (STN)
Trial: 23737536
Drug: Quarter-dose DSA
RxNorm normalized name: Quarter Mate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quarter-dose DSA program
Trial: 8668669
Drug: Ketoprofen 3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 3% gel applied to the knee
Trial: 3048225
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg scopolamine hydrobromide
Trial: 15127155
Drug: Linac radiosurgery
RxNorm normalized name: Linaclotide
DrugBank: Linaclotide (DB08890)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Linac radiosurgery (median dose 20 Gy)
Trial: 2368961
Drug: Inhaled furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled furosemide (3.75 mg/ml for 8 min)
Trial: 9150838
Drug: Inhaled furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled furosemide
Trial: 351664
Drug: Medication and
RxNorm normalized name: CVS Health Medication and Topical Refill Pouch KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication and leaderless group
Trial: 28925059
Drug: Amorolfine 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amorolfine 5% nail lacquer (once-weekly application)
Trial: 28925059
Drug: Ciclopirox 8%
RxNorm normalized name: CICLOPIROX 8% SOLN,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclopirox 8% nail lacquer (once-daily application)
Trial: 28925059
Drug: Urea 40%
RxNorm normalized name: UREA 40% CREAM
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urea 40% ointment/bifonazole 1% cream combination (once-daily application)
Trial: 28925059
Drug: Urea 40%
RxNorm normalized name: UREA 40% CREAM
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urea 40% ointment
Trial: 23586591
Drug: Bifonazole 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifonazole 1% cream
Trial: 18294021
Drug: Intramuscular risperidone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular risperidone, 25 mg every other week
Trial: 10924665
Drug: Bilateral ECT
RxNorm normalized name: ECT-001 expanded cord blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral ECT (all dosage groups)
Trial: 1954636
Drug: Idarubicin (IDA)
DrugBank: Idarubicin (DB01177)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Idarubicin (IDA) 12 mg/m2 daily for 3 days + Cytosine arabinoside 200 mg/m2 daily for 5 days
Trial: 1954636
Drug: Daunorubicin (DNR)
RxNorm normalized name: daunorubicin
DrugBank: Daunorubicin (DB00694)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daunorubicin (DNR) 50 mg/m2 daily for 3 days + Cytosine arabinoside 200 mg/m2 daily for 5 days
Trial: 6908875
Drug: Long-term gestagen
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term gestagen therapy (100 mg medrogestone or medroxyprogesterone acetate daily for 2-5 years)
Trial: 30479087
Drug: Paclitaxel-based hyperthermic
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) with 175 mg/m² for 90 minutes after interval debulking surgery (IDS)
Trial: 24882554
Drug: Sunitinib 50mg
RxNorm normalized name: sunitinib 50 MG
DrugBank: Sunitinib (DB01268)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sunitinib 50mg daily (4 weeks on, 2 weeks off)
Trial: 16500662
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (Simvastatin 20mg and Losartan 100mg)
Trial: 31421426
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no LMWH therapy)
Trial: 26986096
Drug: Dexlansoprazole MR-based
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR-based triple therapy (60 mg once daily, clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily)
Trial: 26986096
Drug: Rabeprazole-based triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole-based triple therapy (20 mg twice daily, clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily)
Trial: 26986096
Drug: Dexlansoprazole MR-based
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR-based triple therapy
Trial: 25201463
Drug: Mg group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mg group
Trial: 20447229
Drug: Drug dependence
RxNorm normalized name: Vitamin K-dependent protein S
DrugBank: Protein S human (DB13149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug dependence treatment trials
Trial: 20447229
Drug: Trials comparing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trials comparing widely different treatments
Trial: 18490084
Drug: Infants with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infants with apnea who participated in the vaccine trial
Trial: 18490084
Drug: Infants from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infants from the vaccine trial control group
Trial: 7571769
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (2 x 40 mg)
Trial: 7571769
Drug: Nisoldipine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine (2 x 10 mg)
Trial: 21487851
Drug: University of
RxNorm normalized name: ALCOHOL 75 mL in 100 mL TOPICAL GEL [University of Michigan]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: University of Wisconsin solution (UW)
Trial: 30687986
Drug: Waitlist control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waitlist control group (WLC) with full access to treatment as usual
Trial: 15165648
Drug: Family‐Focused Grief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family‐Focused Grief Therapy (FFGT)
Trial: 8119064
Drug: Short-duration chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-duration chemotherapy
Trial: 7981389
Drug: Long-duration chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-duration chemotherapy
Trial: 2662740
Drug: APSAC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APSAC treatment
Trial: 236337
Drug: pipradrol‐vitamin (Alertonic)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pipradrol‐vitamin (Alertonic) elixir
Trial: 356078
Drug: no treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no treatment
Trial: 29231341
Drug: Diane-35 (western
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diane-35 (western medication)
Trial: 25331845
Drug: Unilateral baroreflex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral baroreflex activation therapy (BAT)
Trial: 25331845
Drug: Bilateral baroreflex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral baroreflex activation therapy (BAT)
Trial: 21471085
Drug: Vardenafil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil (5 mg twice daily)
Trial: 17418218
Drug: Roxithromycin 300
RxNorm normalized name: roxithromycin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin 300 mg daily for 28 days
Trial: 11985388
Drug: Acetazolamide 500
RxNorm normalized name: acetazolamide 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide 500 mg daily
Trial: 27018419
Drug: Gabapentin 250
RxNorm normalized name: GABAPENTIN 250MG/5ML SOLN,ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 250 mg
Trial: 20819324
Drug: Acetaminophen (4000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (4000 mg/day)
Trial: 8002646
Drug: Prednisone therapy
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone therapy
Trial: 12804077
Drug: 7.5 g
RxNorm normalized name: glucose 15 GM per 37.5 GM Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 g of aromatics inunction
Trial: 11112238
Drug: Raloxifene 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 30 mg
Trial: 9364981
Drug: High levels
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High levels of antiprothrombin antibodies
Trial: 17891382
Drug: Bromocriptine (dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (dopamine D2 agonist)
Trial: 17891382
Drug: Haloperidol (dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (dopamine D2 antagonist)
Trial: 10483801
Drug: Saline (S)
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline (S) containing 100 mmol of NaCl x l(‐1)
Trial: 8709370
Drug: Intravesical capsaicin
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravesical capsaicin (10 microM, twice weekly for 1 month)
Trial: 31246370
Drug: Combined ACT
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined ACT + DBT + FAP therapy group (n = 23)
Trial: 20191935
Drug: Gaboxadol 10
RxNorm normalized name: Gaboxadol
DrugBank: Gaboxadol (DB06554)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gaboxadol 10 mg
Trial: 19094161
Drug: Zolpidem 5
RxNorm normalized name: zolpidem 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 5 mg (active control)
Trial: 9251634
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (sulphasalazine 2 g/day, methotrexate 7.5 mg/week, prednisolone initially 60 mg/day tapered to 7.5 mg/day)
Trial: 22369393
Drug: Lactobacillus (510
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus (510 mg/day for a median of 4.0 days)
Trial: 16192835
Drug: LY354740 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY354740 (100 or 200 mg)
Trial: 16192835
Drug: Paroxetine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (60 mg)
Trial: 9790491
Drug: Intensive individual
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive individual CBT administered by a skilled therapist
Trial: 2562096
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (including alkalinized solutions)
Trial: 31481106
Drug: Riociguat (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riociguat (maximum of 2.5 mg three times daily)
Trial: 28820780
Drug: Exenatide (1‐h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (1‐h bolus of 0.05 µg/min followed by a constant infusion of 0.025 µg/min)
Trial: 28820780
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (control group)
Trial: 19454870
Drug: Lacosamide 200
RxNorm normalized name: lacosamide 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacosamide 200 mg/d
Trial: 25263393
Drug: Rifampicin 450
RxNorm normalized name: Rifampicin 450 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin 450 mg/day for 7 days
Trial: 9297650
Drug: Tannin‐fluoride preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tannin‐fluoride preparation
Trial: 2942167
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (IB) 120 micrograms delivered by a metered dose inhaler (MDI)
Trial: 30982549
Drug: New-generation drug-eluting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New-generation drug-eluting stents (DES)
Trial: 27026339
Drug: Umeclidinium (UMEC)
RxNorm normalized name: Umeclidinium
DrugBank: Umeclidinium (DB09076)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Umeclidinium (UMEC) 15.6, 31.25, 62.5, 125, and 250 mcg once daily; 15.6 and 31.25 mcg twice daily
Trial: 26293451
Drug: Aliskiren add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren add-on therapy to ARB
Trial: 17056122
Drug: Valproate (500-1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valproate (500-1500 mg/day)
Trial: 17056122
Drug: Olanzapine (7.5-15.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (7.5-15.0 mg/day)
Trial: 16083201
Drug: Treated traction
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treated traction with routine conservative treatment
Trial: 7846219
Drug: Metoprolol (14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (14 mg)
Trial: 2923591
Drug: Atropine sulfate
RxNorm normalized name: Atropine Sulfate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulfate (2 mg)
Trial: 30475960
Drug: Apple flavanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apple flavanol extract (70 mg monomeric flavanols, 65 mg PCs)
Trial: 30475960
Drug: Double dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double dose of apple flavanol extract (140 mg monomeric flavanols, 130 mg PCs)
Trial: 30475960
Drug: Apple PC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apple PC extract (130 mg PCs, 6.5 mg monomeric flavanols)
Trial: 10410825
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion
Trial: 29933272
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion
Trial: 8836934
Drug: Levodopa (LD)
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa (LD) and carbidopa (300 mg and 75 mg respectively) with entacapone (400 mg)
Trial: 8836934
Drug: Levodopa (LD)
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa (LD) and carbidopa (300 mg and 75 mg respectively) with placebo
Trial: 29806132
Drug: Curcumin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (500 mg capsules, total: 1,000 mg twice daily for 12 weeks)
Trial: 26497665
Drug: Motivational enhancement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational enhancement therapy plus cognitive behavioural therapy
Trial: 22104388
Drug: Emergency medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emergency medicine (EM) physicians
Trial: 22104388
Drug: Pediatric emergency
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pediatric emergency medicine (PEM) physicians
Trial: 22913889
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus colesevelam
Trial: 21672339
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus placebo
Trial: 30047216
Drug: Semaglutide 0.25
RxNorm normalized name: SEMAGLUTIDE 0.25MG/0.375ML INJ PEN 3ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide 0.25 mg
Trial: 24441673
Drug: Topically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topically applied tazarotene for chemotherapy of BCC lesions
Trial: 12819076
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate (45 mg elemental zinc thrice daily for 9 days starting 2 days before each vaccine dose)
Trial: 1610710
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg fusidic acid, administered twice daily for 6 days
Trial: 6092554
Drug: Alternating chemotherapy
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating chemotherapy (VAM)
Trial: 6092554
Drug: Sequential chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential chemotherapy (POCC)
Trial: 26843153
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation for 28 days during antimalarial treatment
Trial: 26843153
Drug: No iron
RxNorm normalized name: No Iron Multivitamin with Minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No iron supplementation during antimalarial treatment
Trial: 9232361
Drug: 1.0 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g/kg glucose
Trial: 9232361
Drug: 0.5 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg glucose
Trial: 6311913
Drug: DPT +
RxNorm normalized name: Diphtheria, Pertussis, and Tetanus Vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPT + PRP vaccine
Trial: 6311913
Drug: DPT vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPT vaccine
Trial: 29726319
Drug: Outpatient chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient chemotherapy (group B: three treatments in an outpatient clinic followed by four at home)
Trial: 26730818
Drug: TPV/r 500/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPV/r 500/100 mg
Trial: 26730818
Drug: TPV/r 500/200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPV/r 500/200 mg
Trial: 24138537
Drug: LPV/r 400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPV/r 400/100 mg
Trial: 1993488
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg omeprazole once daily
Trial: 8618582
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg famotidine twice daily
Trial: 12719045
Drug: rocuronium (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rocuronium (0.9 mg kg(‐1))
Trial: 12719045
Drug: mivacurium (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mivacurium (0.25 mg kg(‐1))
Trial: 11303324
Drug: Elevated homocysteine
RxNorm normalized name: mecysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated homocysteine level defined as > or = 12.83 mumol/L
Trial: 11303324
Drug: 5 mumol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mumol/L increment in homocysteine level
Trial: 1290619
Drug: Losartan (DuP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (DuP 753, MK‐954) at doses of 5, 10, 20, 40, 80, and 120 mg
Trial: 6365501
Drug: Blood-glucose self-testing
RxNorm normalized name: BLOOD/GLUCOSE/LEUKOCYTES/PROTEIN TEST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood-glucose self-testing (5 tests daily)
Trial: 23958540
Drug: Linaclotide 290
RxNorm normalized name: LINACLOTIDE 290MCG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linaclotide 290 μg once daily for 26 weeks
Trial: 21081243
Drug: Metreleptin (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metreleptin (0.04 mg/kg subcutaneously once daily; n = 5)
Trial: 10834715
Drug: 0.2 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg/day of rHGH
Trial: 8864715
Drug: Pentoxifylline 400
RxNorm normalized name: pentoxifylline 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline 400 mg t.i.d. for 9 months
Trial: 1741200
Drug: Continuous amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous amoxicillin (twice a day every day for up to 4 months)
Trial: 1741200
Drug: Intermittent amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent amoxicillin (twice a day only when respiratory symptoms developed for up to 4 months)
Trial: 1741200
Drug: Continuous amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous amoxicillin
Trial: 27905821
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of booster hepatitis B vaccination (0-1-6 month, 20 µg)
Trial: 22027731
Drug: Drug-eluting balloon
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting balloon (DEB)
Trial: 16854683
Drug: Mifepristone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone (10 mg)
Trial: 15572495
Drug: Levonorgestrel (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel (2 doses of 750 microg given 12 hours apart)
Trial: 31763316
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical treatment (Group B)
Trial: 29348382
Drug: Ophiocephalus striatus
RxNorm normalized name: Labrus striatus flesh
DrugBank: Black sea bass (DB15547)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ophiocephalus striatus extract (10 g per day for 14 days)